This discrepancy may be explained by differences in experimental design, as TRIM72's negative effects on insulin signaling appear to be specific to models of severe diabetes where it exacerbates, rather than initiates, metabolic dysfunction [26]. This evidence concerns the gene TRIM72 and diabetes mellitus.